Related Experiment Video
Updated: Jun 26, 2026
07:53
Assessment of Neuromuscular Function Using Percutaneous Electrical Nerve Stimulation
Published on: September 13, 2015
Personalized neuromuscular blockade through control: clinical and technical evaluation.
Margarida M Silva1, Teresa Mendonca, Simao Esteves
1DMA, FCUP, Rua do Campo Alegre, 687, 4169-007 Porto, Portugal.
Summary
This study analyzed surgeries using automatic closed-loop control for neuromuscular blockade. Results suggest patient-specific drug infusion control in anesthesia is a valuable next step for improved surgical care.
Area of Science:
- Anesthesiology
- Biomedical Engineering
- Clinical Informatics
Background:
- Neuromuscular blockade is crucial for surgical procedures.
- Manual control of neuromuscular blockade can be challenging.
- Automatic closed-loop control offers potential for improved drug delivery.
Purpose of the Study:
- To statistically analyze clinical data from surgeries using automatic closed-loop control of neuromuscular blockade.
- To evaluate the performance of four different control strategies.
- To assess the feasibility of personalized drug infusion control in anesthesia.
Main Methods:
- Statistical analysis of clinical data.
- Application of four distinct closed-loop control strategies.
- Clinical and technical evaluation of the control system.
- Analysis of transient and steady-state behavior.
Main Results:
- The control system demonstrated effectiveness in managing neuromuscular blockade.
- Analysis revealed insights into patient dynamics relevant to drug infusion.
- Transient and steady-state behaviors were thoroughly characterized.
Conclusions:
- Automatic closed-loop control is a promising approach for neuromuscular blockade management.
- Patient dynamics are critical for designing effective control strategies.
- The findings provide a foundation for developing personalized anesthesia drug infusion systems.
Related Concept Videos
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...